This is proposed as a part of the symposia focused on Clinical Pharmacology in the Era of Big Data. The session will discuss the use of wearable devices for clinical research during the COVID 19 pandemic. The use of wearables, also known as biometric monitoring technologies, has increased dramatically during the pandemic as many medical appointments and clinical trial study visits moved to a remote mode. These devices present a feasible opportunity for remote data collection with appropriate validation and are likely to shape the future of drug development.
Discuss commonalities and distinctions between laboratory biomarker assays and digitally measured biomarkers.
Learn about considerations and decision models for transitioning from traditional in-person clinical measurements to a remote at-home data collection in the time of COVID-19 pandemic
Use case studies examples to discuss some of the challenges and opportunities for collecting data remotely in clinical trials